CRYSTALLINE FORMS OF IRAK DEGRADERS

The present disclosure relates generally to various forms, salts and compositions of compounds useful for the modulation of one or more interleukin-1 receptor-associated kinases ("IRAK") via ubiquitination and/or degradation and uses of the same in the treatment various diseases. La présen...

Full description

Saved in:
Bibliographic Details
Main Authors CORSON, Don, ZHENG, Xiaozhang
Format Patent
LanguageEnglish
French
Published 09.12.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates generally to various forms, salts and compositions of compounds useful for the modulation of one or more interleukin-1 receptor-associated kinases ("IRAK") via ubiquitination and/or degradation and uses of the same in the treatment various diseases. La présente invention concerne de manière générale diverses formes, sels et compositions de composés utiles pour la modulation d'une ou de plusieurs kinases associées au récepteur de l'interleukine-1 ("IRAK") par l'intermédiaire de l'ubiquitination et/ou de la dégradation et leurs utilisations dans le traitement de diverses maladies.
Bibliography:Application Number: WO2021US35747